Metronomics Global Health Initiative

Home page > Projects > In preparation

In preparation

category count 5 billets

AHOPCA is working on a metronomic project

We have been recently in contact with Dr Ligia Fu. Dr Fu is a paediatric oncologist from the Servicio de Hemato-Oncologia Pediatrica in the Hospital Escuela in Tegucigalpa, Honduras. This center is part of the Association of Pediatric Hematology Oncology of Central America (AHOPCA) that gathers Guatemala, El Salvador, Nicaragua, Honduras, Costa Rica, (...)

Dose-Finding of Propranolol in combination with metronomic fixed oral cyclophosphamide based on Bivariate efficacy-tolerability outcome in patients with locally advanced or metastatic angiosarcoma : A collaborative and innovative phase I-II sequential trial

The Pr Sébastien Salas from the Adult Oncology Unit, CHU La Timone, AP-HM, Marseille, France has obtained funding for the PROPAN study (Dose-Finding of Propranolol in combination with metronomic fixed oral cyclophosphamide based on Bivariate efficacy-tolerability outcome in patients with locally advanced or metastatic angiosarcoma : A collaborative and (...)

Ecancer-MGHI "metronomic" interview series

MGHI and Ecancer have agreed to work together to make a series of interviews of the most influent clinicians and researchers involved in the field of metronomics who will gather for the 4th Metronomic Meeting in Milano next June. Ecancer is the leading oncology channel committed to improving cancer communication and education with the goal of (...)

MGHI and GFAOP agreed to work on a metronomic project

The GFAOP (Groupe Francophone Africain en Oncologie Pédaitrique) held its annual meeting in Paris from the 21rst to 23rd of May. MGHI was present to lecture about metronomic chemotherapy following previous discussions with Pr Laila HESSISSEN, and Pr Mhamed Harif current president of the GFAOP. The GFAOP has now 14 units in 14 different hospitals located (...)

PROVIN : Phase I study of a propranolol (Hemangiol®) and oral metronomic vinorelbine (Navelbine®) combination for children and teenagers with refractory/relapsing solid tumors

With 2 grants obtained from the PHRC-K national grants and "l’Etoile de Martin" and drugs provided by Pierre Fabre Oncology we are ready to start our latest pediatric metronomics trial that will combine oral propranolol and oral metronomic navelbine in children with refractory/relapsing solid tumours. The trial is called PROVIN and should start (...)